Holdings
Sanofi
As of Jun 30, 2026, Sanofi reported 9 positions worth US$498M. Largest: Meiragtx Holdings Plc, Inhibrx Biosciences, Inc. and Novavax, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Meiragtx Holdings Plc | 12.2M | US$165M | no change | Jun 30, 2026 |
| Inhibrx Biosciences, Inc. | 1.16M | US$110M | no change | Jun 30, 2026 |
| Novavax, Inc. | 6.88M | US$64.8M | no change | Jun 30, 2026 |
| Anaptysbio, Inc. | 822K | US$55.5M | no change | Jun 30, 2026 |
| Odyssey Therapeutics, Inc. | 1.99M | US$37.3M | new | Jun 30, 2026 |
| Maplight Therapeutics, Inc. | 912K | US$32.7M | no change | Jun 30, 2026 |
| First Tracks Biotherapeutics, Inc. | 822K | US$16.5M | new | Jun 30, 2026 |
| Immuneering Corporation | 2.71M | US$13.5M | no change | Jun 30, 2026 |
| Q32 Bio Inc. | 244K | US$3.11M | no change | Jun 30, 2026 |